Analytes | PsA (BL), n = 41 | PsA (M6), n = 41 | p-value PsA, BL vs M6 | Controls (BL), n = 39 | Controls (M6), n = 39 | p-value controls, BL vs M6 |
---|---|---|---|---|---|---|
TNF-α, pg/mL | 12.92 (9.99–17.20) | 12.49 (9.13–17.09) | 0.234 | 11.66 (8.49–13.54) | 9.60 (7.84–13.01) | 0.003 |
IL-1β, pg/mLa | 12.86 (6.73–19.69) | 10.53 (5.02–19.69) | 0.231 | 12.13 (5.30–14.81) | 8.61 (5.30–14.28) | 0.048 |
IL-6, pg/mLb | 8.72 (6.23–11.18) | 7.53 (5.34–10.03) | 0.444 | 7.23 (5.54–9.47) | 6.90 (4.92–8.33) | 0.005 |
IL-8, pg/mLc | 18.69 (13.55–23.21) | 17.68 (13.53–21.65) | 0.781 | 19.28 (13.86–27.32) | 16.64 (11.85–19.41) | 0.077 |
IL-12/IL-23 p40d, pg/mL | 602.65 (384.93–900.21) | 666.57 (333.38–974.17) | 0.978 | 544.11 (333.38–835.83) | 466.00 (209.26–729.91) | 0.032 |
IL-13, pg/mLe | 906.55 (679.96–1131.63) | 885.07 (561.48–1171.12) | 0.377 | 885.07 (650.51–1103.93) | 777.97 (551.40–1023.60) | 0.053 |
IL-17, pg/mLf | 2.63 (1.58–4.65) | 2.43 (0.41–4.48) | 0.074 | 0.86 (0.41–3.35) | 0.41 (0.41–2.63) | 0.465 |
IL-23, ng/mLg | 0.40 (0.17–0.54) | 0.18 (0.10–0.30) | < 0.001 | 0.54 (0.33–0.71) | 0.23 (0.12–0.34) | < 0.001 |
IFN-γ, pg/mL | 61.98 (43.73–76.34) | 52.09 (40.50–76.34) | 0.134 | 54.73 (43.83–69.95) | 48.80 (40.50–61.98) | 0.006 |
Resistin, ng/mL | 12.83 (10.58–15.77) | 11.81 (10.05–14.91) | 0.341 | 11.82 (9.22–16.42) | 12.45 (9.19–15.04) | 0.315 |
Leptin, ng/mLh | 26.28 (14.35–48.73) | 9.25 (4.40–16.24) | < 0.001 | 38.80 (20.47–59.87) | 14.04 (10.07–26.92) | < 0.001 |
HMW adiponectin, µg/mL | 3.39 (2.13–5.12) | 5.95 (3.78–8.45) | < 0.001 | 4.26 (2.07–6.45) | 5.78 (4.50–7.93) | < 0.001 |
Tot-adiponectin, µg/mL | 4.03 (3.18–6.06) | 5.90 (4.04–7.93) | < 0.001 | 4.16 (3.27–5.11) | 5.67 (4.27–6.70) | < 0.001 |
VAS patients´ global disease activity, mm | 34 (19–61) | 12 (5–51) | 0.001 |  |  |  |
VAS pain, mm | 30 (19–63) | 20 (5–52) | 0.004 |  |  |  |
VAS fatigue, mm | 56 (22–67) | 25 (8–44) | 0.001 |  |  |  |
HAQ, score | 0.63 (0.13–1.00) | 0.25 (0.00–0.69) | < 0.001 |  |  |  |
DAS28CRP, score | 2.9 (2.1–3.7) | 2.5 (1.7–3.0) | < 0.001 |  |  |  |
DAPSA, score | 15.3 (6.6–29.1) | 8.2 (2.8–17.7) | < 0.001 |  |  |  |
BMI, kg/m2 | 35.2 (34.1–38.1) | 29.8 (26.6–31.5) | < 0.001 | 37.7 (36.7–41.5) | 30.4 (27.9–33.2) | < 0.001 |
CRP, mg/L | 4.0 (2.0–8.5) | 2.0 (1.0–6.5) | 0.041 | 4.0 (2.0–6.0) | 2.0 (1.0–4.0) | < 0.001 |